Patent · US Active

HIV inhibiting 5-heterocyclyl pyrimidines

US8575342B2 · kind B2 · utility

0Cited by

4References

24Claims

0Family size

Assignee

Tibotec Pharmaceuticals Ltd. · IE

Inventors

Jérôme Emile Georges Guillemont · Andé, FR
Jan Heeres · Vosselaar, BE
Paulus Joannes Lewi · Turnhout, BE

Key dates

Filing date	Sep 29, 2005
Grant date	Nov 5, 2013
Priority date	—
Expiry date	Jan 25, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Compounds of formula (I), N-oxides, pharmaceutical acceptable salts, quaternary amines or stereoisomeric forms thereof, and their use as HIV replication inhibitors,In the formula, -a1=a2-a3=a4- and -b1=b2-b3=b4- may be —C═C—C═C—; X1 may be O, NR1, etc.;R1, R2, R2a, R3, R4 and R5 are assorted substituents as defined in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.